Which of the following vaccines is contraindicated in pregnancy?
A 36-year-old G1P0 woman presents for her first prenatal visit late in her first trimester of pregnancy; she complains of persistent vaginal bleeding, nausea, and pelvic pain. Physical examination is notable for a gravid uterus larger than expected for gestational age. Fetal heart tones are absent. Which of the following is most likely to be true?
At what gestational age does fetal heart activity become detectable by Doppler ultrasound in pregnancy?
What is the minimum recommended daily dosage of folic acid supplementation for women during the preconception period?
What are the approximate daily caloric needs during pregnancy?
Which of the following statements about pregnancy is incorrect?
Which of the following is the most sensitive or gold standard test for assessing HCG in maternal serum?
A 28-year-old woman, G2 P1, at 20 weeks gestation presents with fever, cough, and myalgia for 3 days. Her child at home is also sick. The patient is suspected to have Influenza. What is the best treatment for this patient during pregnancy?
In early pregnancy, what is the typical doubling time of beta-hCG?
What is the best sonological marker for the diagnosis of Down syndrome in the first trimester?
Explanation: **Explanation:** The fundamental principle in prenatal vaccination is that **Live Attenuated Vaccines** are generally **contraindicated** during pregnancy. This is due to the theoretical risk of the live virus crossing the placenta and causing fetal infection or teratogenic effects. **Yellow Fever (Option C)** is a live attenuated viral vaccine. It is contraindicated in pregnancy unless the risk of exposure to the disease (e.g., travel to endemic areas where the risk of infection is high) outweighs the potential risk of vaccination. If a pregnant woman must travel to an endemic zone, the vaccine is administered, but it remains the "most contraindicated" among the options provided. **Why the other options are incorrect:** * **Rabies (Option A):** This is an **inactivated** vaccine. It is safe and indicated for post-exposure prophylaxis in pregnancy because the disease is 100% fatal. * **Hepatitis B (Option B):** This is a **recombinant/subunit** vaccine. It is safe and recommended for pregnant women at high risk of infection. * **Hepatitis A (Option A):** This is an **inactivated** vaccine. It can be administered if there is a high risk of exposure. **High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications (Live Vaccines):** MMR (Measles, Mumps, Rubella), Varicella, BCG, and Oral Polio (OPV). * **The "Rule of 1 Month":** Women should be advised to avoid pregnancy for at least 4 weeks after receiving a live vaccine (especially Rubella). * **Recommended Vaccines:** Tdap (Tetanus, Diphtheria, and acellular Pertussis) is recommended in every pregnancy (ideally between 27–36 weeks) to provide passive immunity to the neonate. * **Influenza:** The **inactivated** injectable flu vaccine is safe and recommended in any trimester during flu season. The intranasal flu vaccine is live and contraindicated.
Explanation: ### Explanation The clinical presentation—**vaginal bleeding, hyperemesis (nausea), pelvic pain, a uterus larger than dates, and absent fetal heart tones**—is a classic triad for **Molar Pregnancy (Hydatidiform Mole)**. **1. Why Option A is Correct:** In a hydatidiform mole, there is an abnormal proliferation of trophoblastic tissue. Since syncytiotrophoblasts produce human chorionic gonadotropin, the massive overgrowth leads to **markedly elevated Beta-hCG levels** (often >100,000 mIU/mL). These extreme levels are responsible for the exaggerated pregnancy symptoms like severe nausea (hyperemesis gravidarum) and the "snowstorm" appearance on ultrasound. **2. Why the Other Options are Incorrect:** * **Option B:** Lower than normal Beta-hCG is typically associated with ectopic pregnancies or impending miscarriages, not molar pregnancies. * **Option C:** In approximately 50% of molar pregnancies, the **uterus is larger than gestational age** due to the rapid proliferation of chorionic villi and accumulated intrauterine blood. * **Option D:** High levels of Beta-hCG can cross-react with the TSH receptor because they share a common alpha-subunit. This leads to a **thyrotoxic state**, resulting in **decreased TSH** and increased T3/T4 levels. **Clinical Pearls for NEET-PG:** * **Diagnosis:** Ultrasound is the gold standard, showing a **"Snowstorm appearance"** (complete mole) or "Swiss cheese" appearance. * **Theca Lutein Cysts:** High hCG can cause bilateral ovarian enlargement (Theca Lutein cysts). * **Complication:** Patients are at risk for early-onset **Preeclampsia** (occurring before 20 weeks gestation). * **Management:** Suction and evacuation followed by serial Beta-hCG monitoring to rule out Gestational Trophoblastic Neoplasia (GTN).
Explanation: ### Explanation **Correct Answer: A. Before 16 weeks** The fetal heart begins to beat at approximately 5.5 to 6 weeks of gestation. However, the timing of detection depends on the modality used: * **Transvaginal Ultrasound (TVS):** Detects cardiac activity as early as **5.5–6 weeks**. * **Transabdominal Ultrasound (TAS):** Detects activity by **7–8 weeks**. * **Handheld Doppler (Electronic):** Can typically detect fetal heart sounds between **10 and 12 weeks** of gestation. * **Pinard Stethoscope (Fetoscope):** Requires more advanced development and can detect sounds by **18–20 weeks**. Since a handheld Doppler can pick up the fetal heart rate as early as the late first trimester (10–12 weeks), "Before 16 weeks" is the most accurate clinical timeframe among the choices. **Why the other options are incorrect:** * **B & C (After 18/20 weeks):** These timeframes are associated with **fetoscopy** (clinical auscultation using a Pinard stethoscope), not Doppler ultrasound. Waiting until 18–20 weeks to confirm heart activity via Doppler would represent a significant clinical delay. * **D (After 24 weeks):** This is well into the second trimester and is far beyond the standard window for initial Doppler detection. **NEET-PG High-Yield Pearls:** * **First sign of pregnancy on USG:** Gestational sac (seen at ~4.5–5 weeks with TVS). * **Yolk sac:** Appears at ~5 weeks; its presence confirms an intrauterine pregnancy. * **Discriminatory Zone:** The level of serum β-hCG at which a gestational sac should be visible (typically **1500–2000 mIU/mL** for TVS). * **Fetal Heart Rate (FHR):** Starts at ~110 bpm in early pregnancy, peaks at ~170 bpm at 9 weeks, and stabilizes to **110–160 bpm** near term.
Explanation: **Explanation:** The correct answer is **400 micrograms (0.4 mg)**. Folic acid is a B-complex vitamin essential for DNA synthesis and amino acid metabolism. During the first few weeks of pregnancy—often before a woman knows she is pregnant—the neural tube closes. Adequate folate levels are critical to prevent **Neural Tube Defects (NTDs)** such as anencephaly and spina bifida. * **Why 400 mcg is correct:** International guidelines (WHO, FIGO) and national protocols (MoHFW, India) recommend a daily dose of 400 mcg starting at least **one month prior to conception** and continuing through the first trimester (12 weeks) to ensure optimal maternal serum and red cell folate levels. * **Why A, B, and C are incorrect:** 10, 40, and 100 micrograms are sub-therapeutic doses. They do not provide sufficient folate to significantly reduce the risk of NTDs in the general population. **High-Yield Clinical Pearls for NEET-PG:** 1. **High-Risk Dosage:** For women with a **previous history** of a child with an NTD, the recommended dose is increased tenfold to **4 mg (4000 mcg)** daily. 2. **Timing:** Supplementation must ideally begin **pre-conceptionally** because the neural tube closes by the **28th day** post-conception. 3. **Other High-Risk Groups:** Women with diabetes, those on anti-epileptic drugs (e.g., Valproate), or those with malabsorption syndromes also require higher doses (5 mg). 4. **Iron-Folic Acid (IFA) Tablet:** Under the *Anemia Mukt Bharat* guidelines, pregnant women are prescribed 60 mg elemental iron and 500 mcg folic acid daily for 180 days starting from the second trimester.
Explanation: **Explanation:** The caloric requirement during pregnancy is calculated based on the pre-pregnancy basal metabolic rate plus the additional energy required for fetal growth, placental development, and maternal tissue expansion. **Why Option C is Correct:** A non-pregnant woman with a sedentary to moderate lifestyle requires approximately **2100–2200 kcal/day**. According to the Indian Council of Medical Research (ICMR) and standard obstetric guidelines (Dutta, Williams), the additional caloric requirement during pregnancy is **+350 kcal/day** (primarily in the 2nd and 3rd trimesters). * Calculation: 2200 (Baseline) + 300 to 350 (Pregnancy increment) ≈ **2500–2550 kcal/day**. Therefore, 2500 calories is the most accurate approximation for the total daily intake. **Why Other Options are Incorrect:** * **Options A & B (1000 & 1500 kcal):** These represent severe caloric restriction. Such low intake leads to intrauterine growth restriction (IUGR), maternal ketosis, and low birth weight. * **Option D (3500 kcal):** This is excessive. Over-nutrition during pregnancy increases the risk of gestational diabetes, macrosomia, and maternal obesity. **High-Yield Clinical Pearls for NEET-PG:** * **Additional Calories:** +350 kcal/day in pregnancy; **+600 kcal/day** during the first 6 months of lactation. * **Protein Requirement:** An additional **+23 g/day** is recommended during pregnancy (Total ~78g). * **Weight Gain:** The average weight gain in a healthy pregnancy (BMI 18.5–24.9) is **11 kg**. * **Iron & Folic Acid:** 60 mg of elemental iron and 400 µg (0.4 mg) of folic acid daily are standard prophylactic doses.
Explanation: ### Explanation The correct answer is **D**, as the statement is clinically inaccurate. **1. Why Option D is Incorrect (The Correct Answer):** In a normal pregnancy, the fundal height reaches the **xiphisternum at 36 weeks**. By **40 weeks**, the fundal height actually **descends** to the level of 32 weeks (between the umbilicus and xiphisternum). This phenomenon is known as **"Lightening"** or "the welcome sign," occurring as the fetal head engages into the maternal pelvis, reducing pressure on the diaphragm. **2. Analysis of Other Options:** * **A. Amenorrhea is the earliest symptom:** In a woman of reproductive age with regular cycles, the sudden cessation of menstruation is the first clinical sign of pregnancy. * **B. Fetal heart sounds (FHS) at 18–20 weeks:** Using a traditional **Pinard stethoscope**, FHS are typically audible between 18 and 20 weeks. (Note: Doppler can detect FHS earlier, around 10–12 weeks). * **C. Fetal parts at 20 weeks:** Palpation of fetal parts (fetal poles and trunk) via abdominal examination usually becomes possible around the 20th week of gestation. **3. NEET-PG High-Yield Pearls:** * **Fundal Height Landmarks:** * 12 weeks: Just felt per abdomen (at pubic symphysis). * 24 weeks: At the level of the **umbilicus**. * 36 weeks: At the **xiphisternum**. * **Quickening:** The first perception of fetal movement by the mother occurs at **18 weeks** in primigravida and **16 weeks** in multigravida. * **Hegar’s Sign:** Softening of the isthmus, a clinical sign of pregnancy seen between 6–10 weeks.
Explanation: **Explanation:** Human Chorionic Gonadotropin (hCG) is a glycoprotein hormone produced by the syncytiotrophoblast. It consists of an alpha (α) subunit (identical to LH, FSH, and TSH) and a beta (β) subunit (unique to hCG). **1. Why Radioimmune Assay (RIA) is the Gold Standard:** The **Radioimmune Assay (RIA)** is considered the most sensitive and specific method (Gold Standard) for measuring serum hCG. It utilizes the principle of competitive binding between radiolabeled and unlabeled antigens for specific antibodies. Its high sensitivity allows for the detection of pregnancy as early as 8–9 days after fertilization (even before a missed period) and is crucial for monitoring ectopic pregnancies and gestational trophoblastic diseases (GTD). **2. Analysis of Incorrect Options:** * **ELISA:** While highly popular in modern clinical practice due to its speed, lack of radiation, and high accuracy, it is generally considered a "screening" or "routine" quantitative tool rather than the historical gold standard for absolute sensitivity. * **Latex Test (Latex Agglutination Inhibition):** This is an older immunological test used for urine pregnancy tests. It has a high threshold (detection limit ~500–1000 mIU/mL) and is prone to false positives/negatives. * **Bioassay:** These were the earliest tests (e.g., Aschheim-Zondek, Galli-Mainini) involving the injection of patient urine into animals (mice, frogs). They are obsolete due to being time-consuming, expensive, and lacking specificity. **Clinical Pearls for NEET-PG:** * **Doubling Time:** In a healthy intrauterine pregnancy, serum β-hCG levels double approximately every **48 hours** during the first 8 weeks. * **Peak Levels:** hCG levels reach their peak at **8–10 weeks** (approx. 100,000 mIU/mL) and then decline to a plateau. * **Discriminatory Zone:** The level of hCG at which a gestational sac should be visible on TVS is **1500–2000 mIU/mL**. * **Subunit Specificity:** Always measure the **beta (β)** subunit to avoid cross-reactivity with LH.
Explanation: **Explanation:** **Correct Answer: C. Oseltamivir for 5 days** **Medical Concept:** Influenza in pregnancy is associated with a higher risk of severe morbidity, including pneumonia and respiratory failure, due to physiological changes in the cardiovascular and respiratory systems. **Oseltamivir (a Neuraminidase Inhibitor)** is the drug of choice for treating influenza in pregnant and postpartum women. It is most effective when started within 48 hours of symptom onset, but it should be administered even after 48 hours in pregnant patients due to the high risk of complications. The standard therapeutic dose is **75 mg twice daily for 5 days**. **Analysis of Incorrect Options:** * **Options A & B (Amantadine):** Amantadine and Rimantadine are adamantanes. They are no longer recommended for the treatment of influenza because of widespread resistance among circulating influenza A viruses and their lack of efficacy against influenza B. Furthermore, amantadine is potentially teratogenic. * **Option D:** Combination therapy with adamantanes is not indicated due to the resistance patterns mentioned above. A 10-day course is typically reserved for prophylaxis in specific high-risk exposures, not standard treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Oseltamivir (75 mg BID for 5 days) is the preferred antiviral in pregnancy. * **Chemoprophylaxis:** For pregnant women with close contact exposure, Oseltamivir (75 mg OD for 7–10 days) is recommended. * **Vaccination:** The inactivated influenza vaccine is **safe and recommended** for all pregnant women during any trimester of pregnancy. It provides passive immunity to the newborn. * **Category:** Oseltamivir is a Pregnancy Category C drug, but its benefits in preventing maternal complications far outweigh the theoretical risks.
Explanation: ### Explanation **Correct Answer: B. 48 hours** In a normal intrauterine pregnancy, serum beta-hCG levels rise exponentially during the first trimester. The standard clinical benchmark is that **beta-hCG levels should double approximately every 48 hours** (specifically, a minimum rise of 35–53% over 48 hours is considered the lower limit of normal). This doubling occurs until levels peak at around 8–11 weeks of gestation (reaching approximately 100,000 mIU/mL) before gradually declining and leveling off. **Analysis of Incorrect Options:** * **A. 24 hours:** While hCG rises rapidly, a doubling time of 24 hours is faster than the physiological norm and is not the standard clinical expectation. * **C. 96 hours:** As pregnancy progresses (after 6–7 weeks or when levels exceed 6,000 mIU/mL), the doubling time slows down to approximately 96 hours. However, in "early" pregnancy, 48 hours is the classic teaching. * **D. 2 weeks:** This is far too slow. A failure of hCG to rise appropriately is a hallmark of an abnormal pregnancy (e.g., ectopic pregnancy or impending miscarriage). **Clinical Pearls for NEET-PG:** 1. **Discriminatory Zone:** This is the beta-hCG level above which a gestational sac should be visible on ultrasound. * **Transvaginal Sonography (TVS):** 1,500–2,000 mIU/mL. * **Transabdominal Sonography (TAS):** 6,000–6,500 mIU/mL. 2. **Ectopic Pregnancy:** Suspect this if the beta-hCG rise is <35% over 48 hours or if levels are above the discriminatory zone with an empty uterus. 3. **Molar Pregnancy:** Characterized by abnormally high beta-hCG levels (often >100,000 mIU/mL) for the calculated gestational age. 4. **Source:** hCG is secreted by the **syncytiotrophoblast** cells of the placenta.
Explanation: **Explanation:** **1. Why Nuchal Translucency (NT) is the Correct Answer:** Nuchal Translucency refers to the subcutaneous collection of fluid behind the fetal neck, visualized via ultrasound between **11 and 13+6 weeks** of gestation (CRL 45–84 mm). An increased NT thickness (typically >3.0 mm or >95th percentile) is the most sensitive and specific first-trimester sonological marker for Down syndrome (Trisomy 21). It is associated with cardiac failure due to structural defects, venous congestion, or altered extracellular matrix composition in aneuploid fetuses. **2. Why the Other Options are Incorrect:** * **Fetal Heart Rate (B):** While tachycardia is sometimes noted in Trisomy 13, fetal heart rate is not a reliable or specific screening marker for Down syndrome. * **Microcephaly (C):** This is a structural abnormality often associated with Zika virus or Trisomy 18, but it is typically diagnosed in the **second or third trimester**, not the first. * **Polyhydramnios (D):** This is an excess of amniotic fluid usually detected in the **late second or third trimester**. While it can be associated with GI atresias (common in Down syndrome), it is not a primary diagnostic marker for screening. **3. High-Yield Clinical Pearls for NEET-PG:** * **Combined Test:** The best first-trimester screening method is the "Combined Test" (NT + PAPP-A + β-hCG), which has a detection rate of ~90%. * **Nasal Bone:** The absence of the nasal bone in the first trimester is the *second* most important marker for Down syndrome. * **Soft Markers (2nd Trimester):** If you miss the first-trimester window, look for markers like **Echogenic Intracardiac Focus (EIF)**, **Sandal Gap**, and **Duodenal Atresia** (Double bubble sign). * **Definitive Diagnosis:** Remember that NT is a *screening* tool. Definitive diagnosis requires invasive testing like **Chorionic Villus Sampling (CVS)** or **Amniocentesis**.
Preconception Counseling
Practice Questions
Pregnancy Diagnosis and Dating
Practice Questions
Routine Antenatal Assessments
Practice Questions
Maternal Physiological Changes
Practice Questions
Nutrition in Pregnancy
Practice Questions
Screening Tests in Pregnancy
Practice Questions
Fetal Growth Assessment
Practice Questions
High-Risk Pregnancy Identification
Practice Questions
Antenatal Complications Management
Practice Questions
Psychosocial Aspects of Pregnancy
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free